1Zouboulis CC.Retinoids--which dermatological indications will benefit in the near future? Skin Pharmacol Appl Skin Physiol,2001,14: 303-315.
2Cather J, Menter A. Novel therapies for psoriasis. Am J Clin Dermatol, 2002, 3:159-173.
3Jackson CG.Immunomodulating drugs in the management of psoriatic arthritis. Am J Clin Dermatol, 2001, 2: 367-375.
4Nyirady J, Grossman RM, Nighland M, et al. A comparative trial of two retinoids commonly used in the treatment of acne vulgaris. J Dermatolog Treat, 2001, 12: 149157.
5Wysowski DK, Swann J, Vega A. Use of isotretinoin (Accutane) in the United States: rapid increase from 1992 through 2000.J Am Acad Dermatol,2002,46:505-509.
6Suchin KR, Cucchiara AJ, Gottleib SL, et al. Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution. Arch Dermatol, 2002, 138: 1054-1060.
7Allison DS, El-Azhary RA, Calobrisi SD,et al. Pityriasis rubra pilaris in children. J Am Acad Dermatol, 2002, 47: 386-389.
8Li YH, Gao XH, He CD, et al. Detection of human papillomavirus and response to oral arotinoid ethylester in 2 cases of Darier disease. Arch Dematol, 2002, 138:695-696.
9Baran R. Pyogenic granuloma-like lesions associated with topical retinoid therapy.J Am Acad Dermatol, 2002, 47: 970.
10Onder M, Oztas MO, Oztas P. Isotretinoininduced nail fragility and onycholysis. J Dermatology Treat, 2001, 12:115-116.
